Glenmark set to launch FabiFlu 400mg for Covid-19 treatment in India
New Delhi: Glenmark Pharmaceuticals, a research-led global pharmaceutical company, Thursday announced that it is set to introduce a 400 mg ...
Read moreDetails
New Delhi: Glenmark Pharmaceuticals, a research-led global pharmaceutical company, Thursday announced that it is set to introduce a 400 mg ...
Read moreDetailsNew Delhi: Glenmark Pharmaceuticals said Wedensday that the Phase 3 clinical trial of antiviral drug Favipiravir is giving hope. Glenmark ...
Read moreDetailsNew Delhi: Shares of Glenmark Pharmaceuticals on Monday tumbled nearly 6 per cent after India's drug regulator sought clarification from ...
Read moreDetailsNew Delhi: Drug firm Glenmark Pharmaceuticals said Monday it has cut price of antiviral drug ‘Favipiravir’. The drug is sold under ...
Read moreDetails
By Aakar Patel A few thoughts on the Cockroach Janata Party’s protest come to mind. The hunger strike by activists,...
Read moreDetails
Bhubaneswar: The Mission Shakti department Friday signed a pact with the International Crops Research Institute for the Semi-Arid Tropics (ICRISAT)...
Read moreDetails
Governments are quick to invoke the rule of law but are less good at living by it. The Department of...
Read moreDetails
With the retail inflation in India climbing to 4.38 per cent, tell tale signs of the global economic crisis have...
Read moreDetails
